SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Advanced Viral Research CP (ADVR)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: OLD JAKE JUSTUS who wrote (2238)5/20/1997 6:21:00 PM
From: Tom Jones   of 2281
 
I suggest you consolidate all of these ADVR threads. It's easy to do and would make life easier for us ADVR activists.

I'm not familiar with the news story you mentioned, but sadly do I doubt they were talking about our flagship Reticulose. There are so many of these start-up biotechs making the claims that were discussed in the report you described. That speaks to the point I made earlier. By investing in sound public relations initiatives, ADVR could help the public (specifically the financial public) cut through the bullshit and get to the science behind the news.

In our case with ADVR and Reticulose, science is the news. When this news is reported by some key financial media outlets, we'll see the stock begin to hit new highs.

Mr. Bregman, Dr. Hirschman, hear our call. Get a public relations firm on board who know what they're talking about and know who you need to talk to. Please.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News